These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 1375535)

  • 1. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
    Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of malignant conversion in skin carcinogenesis.
    Yuspa SH; Greenhalgh DA
    Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte.
    Woodworth CD; Michael E; Smith L; Vijayachandra K; Glick A; Hennings H; Yuspa SH
    Carcinogenesis; 2004 Sep; 25(9):1771-8. PubMed ID: 15105299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis.
    Hennings H; Glick AB; Greenhalgh DA; Morgan DL; Strickland JE; Tennenbaum T; Yuspa SH
    Proc Soc Exp Biol Med; 1993 Jan; 202(1):1-8. PubMed ID: 8424089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the regulation of intracellular calcium in normal and neoplastic keratinocytes are not caused by ras gene mutations.
    Kruszewski FH; Hennings H; Tucker RW; Yuspa SH
    Cancer Res; 1991 Aug; 51(16):4206-12. PubMed ID: 1907882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
    Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts.
    Strickland JE; Greenhalgh DA; Koceva-Chyla A; Hennings H; Restrepo C; Balaschak M; Yuspa SH
    Cancer Res; 1988 Jan; 48(1):165-9. PubMed ID: 3121168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
    Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
    Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
    Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
    Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
    Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy.
    Greenhalgh DA; Wang XJ; Eckhardt JN; Roop DR
    Cell Growth Differ; 1995 May; 6(5):579-86. PubMed ID: 7544154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular basis for tumor promotion in mouse skin.
    Yuspa SH
    Princess Takamatsu Symp; 1983; 14():315-26. PubMed ID: 6394593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
    Owens DM; Watt FM
    Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.
    Rutberg SE; Adams TL; Glick A; Bonovich MT; Vinson C; Yuspa SH
    Cancer Res; 2000 Nov; 60(22):6332-8. PubMed ID: 11103794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes.
    Caulín C; Bauluz C; Gandarillas A; Cano A; Quintanilla M
    Exp Cell Res; 1993 Jan; 204(1):11-21. PubMed ID: 7677983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis.
    Miller DR; Viaje A; Rotstein J; Aldaz CM; Conti CJ; Slaga TJ
    Cancer Res; 1989 Jan; 49(2):410-4. PubMed ID: 2491955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.